493
Views
12
CrossRef citations to date
0
Altmetric
Reviews

The development of models for the evaluation of pulmonary drug disposition

, , &
Pages 487-505 | Published online: 08 Jan 2013

Bibliography

  • Dale O, Brown BR Jr. Clinical pharmacokinetics of the inhalational anaesthetics. Clin Pharmacokinet 1987;12(3):145-67
  • Dalby R, Suman J. Inhalation therapy: technological milestones in asthma treatment. Adv Drug Deliv Rev 2003;55(7):779-91
  • Reiser J, Warner JO. Inhalation treatment for asthma. Arch Dis Child 1986;61(1):88-94
  • Falagas ME, Michalopoulos A, Metaxas EI. Pulmonary drug delivery systems for antimicrobial agents: facts and myths. Int J Antimicrob Agents 2010;35(2):101-6
  • Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med 2012;6(1):91-101
  • Frederiksen B, Pressler T, Hansen A, Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr 2006;95(9):1070-4
  • Anttila S, Hukkanen J, Hakkola J, Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J Respir Cell Mol Biol 1997;16(3):242-9
  • Labiris NR, Dolovich MB. Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003;56(6):600-12
  • Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 2009;29(1):196-212
  • Donovan MJ, Gibbons A, Herpin MJ, Novel dry powder inhaler particle-dispersion systems. Ther Deliv 2011;2(10):1295-311
  • Al-Hallak MH, Sarfraz MK, Azarmi S, Distribution of effervescent inhalable nanoparticles after pulmonary delivery: an in vivo study. Ther Deliv 2012;3(6):725-34
  • Housman ST, Pope JS, Russomanno J, Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers. Antimicrob Agents Chemother 2012;56(5):2627-34
  • Husain S, Capitano B, Corcoran T, Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients. Transplantation 2010;90(11):1215-19
  • Merkus PJFM, Hislop AA. Lung development from infancy to adulthood. Eur Respir Monogr 2006;37:8-21
  • Mathias NR, Yamashita F, Lee VHL. Respiratory epithelial cell culture models for evaluation of ion and drug transport. Adv Drug Deliv Rev 1996;22(1-2):215-49
  • Steimer A, Haltner E, Lehr CM. Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med 2005;18(2):137-82
  • Stone KC, Mercer RR, Gehr P, Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 1992;6(2):235-43
  • Schmitz G, Muller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 1991;32(10):1539-70
  • Dobbs LG. Isolation and culture of alveolar type II cells. Am J Physiol 1990;258(4 Pt 1):L134-47
  • Plopper CG. Structure and function of the lung. In: Jones TC, Dungworth DL, Mohr U, editors. Respiratory system. Springer Verlag; Berlin: 1996. p. 135-50
  • Ding XX, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol 2003;43:149-73
  • Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994;26(2):144-60
  • Bosquillon C. Drug transporters in the lung-do they play a role in the biopharmaceutics of inhaled drugs? J Pharm Sci 2010;99(5):2240-55
  • Bleasby K, Castle JC, Roberts CJ, Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica 2006;36(10-11):963-88
  • Ehrhardt C, Kneuer C, Bies C, Salbutamol is actively absorbed across human bronchial epithelial cell layers. Pulm Pharmacol Ther 2005;18(3):165-70
  • Mukherjee M, Pritchard DI, Bosquillon C. Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro. Int J Pharm 2012;426(1-2):7-14
  • van der Deen M, de Vries EG, Timens W, ATP-binding cassette (ABC) transporters in normal and pathological lung. Respir Res 2005;6:59
  • Togami K, Chono S, Morimoto K. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. Pharmazie 2012;67(5):389-93
  • Gnadt M, Trammer B, Freiwald M, Methacholine delays pulmonary absorption of inhaled beta(2)-agonists due to competition for organic cation/carnitine transporters. Pulm Pharmacol Ther 2012;25(1):124-34
  • Elkiweri IA, Zhang YL, Christians U, Competitive substrates for P-glycoprotein and organic anion protein transporters differentially reduce blood organ transport of fentanyl and loperamide: pharmacokinetics and pharmacodynamics in Sprague-Dawley rats. Anesth Analg 2009;108(1):149-59
  • Upton RN, Doolette DJ. Kinetic aspects of drug disposition in the lungs. Clin Exp Pharmacol Physiol 1999;26(5-6):381-91
  • McCullagh A, Rosenthal M, Wanner A, The bronchial circulation-worth a closer Look: a review of the relationship between the bronchial vasculature and airway inflammation. Pediatr Pulm 2010;45(1):1-13
  • Codrons V, Vanderbist F, Ucakar B, Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs. J Pharm Sci 2004;93(5):1241-52
  • Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of beta(2)-agonist particle size. Am J Resp Crit Care 2005;172(12):1497-504
  • Olsson B, Bondesson E, Borgstrom L, Pulmonary drug metabolism, clearance, and absorption. In: Rathbone MJ, editors. Adv Del Sci Technol 2011. p. 21-50
  • Ninio S, Yamboliev I, Kovacheva S. High lung uptake of 99mTc-multilamellar liposomes after intravenous administration in rats and rabbits. Pharmazie 1994;49(5):353-6
  • Islam N, Cleary MJ. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery–a review for multidisciplinary researchers. Med Eng Phys 2012;34(4):409-27
  • Mobley C, Hochhaus G. Methods used to assess pulmonary deposition and absorption of drugs. Drug Discov Today 2001;6(7):367-75
  • Chow AHL, Tong HHY, Chattopadhyay P, Shekunov BY. Particle engineering for pulmonary drug delivery. Pharm Res 2007;24(3):411-37
  • Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 2006;58(9-10):1030-60
  • Lansley AB. Mucociliary clearance and drug-delivery via the respiratory-tract. Adv Drug Deliv Rev 1993;11(3):299-327
  • Haley PJ, Muggenburg BA, Weissman DN, Bice DE. Comparative morphology and morphometry of alveolar macrophages from six species. Am J Anat 1991;191(4):401-7
  • Byron PR. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation. J Pharm Sci 1986;75(5):433-8
  • Schulz H, Brand P, Heyder J. Particle deposition in the respiratory tract. In: Gehr P, Heyder J, editors. Particle-lung interactions. Marcel Dekker, New York; 2000. p. 228-86
  • Wiedmann TS, Bhatia R, Wattenberg LW. Drug solubilization in lung surfactant. J Control Release 2000;65(1-2):43-7
  • Patton JS. Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 1996;19(1):3-36
  • Patton JS, Fishburn CS, Weers JG. The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc 2004;1(4):338-44
  • Eljamal M, Nagarajan S, Patton JS. In situ and in vivo methods for pulmonary delivery. Pharm Biotechnol 1996;8:361-74
  • Effros RM, Mason GR. Measurements of pulmonary epithelial permeability in vivo. Am Rev Respir Dis 1983;127(5 Pt 2):S59-65
  • Kim KJ, Matsukawa Y, Yamahara H, Absorption of intact albumin across rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 2003;284(3):L458-65
  • Spiekermann GM, Finn PW, Ward ES, Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung. J Exp Med 2002;196(3):303-10
  • Deshpande D, Toledo-Velasquez D, Wang LY, Receptor-mediated peptide delivery in pulmonary epithelial monolayers. Pharm Res 1994;11(8):1121-6
  • Yang W, Peters JI, Williams RO III. Inhaled nanoparticles–a current review. Int J Pharm 2008;356(1-2):239-47
  • Rodgers T, Leahy D, Rowland M. Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 2005;94(6):1259-76
  • Roerig DL, Kotrly KJ, Ahlf SB, Effect of propranolol on the first pass uptake of fentanyl in the human and rat lung. Anesthesiology 1989;71(1):62-8
  • Matot I, Neely CF, Katz RY, Marshall BE. Fentanyl and propofol uptake by the lung - effect of time between injections. Acta Anaesth Scand 1994;38(7):711-15
  • Miniati M, Paci A, Cocci F, Mitochondria act as a reservoir for the basic amine HIPDM in the lung. Eur Respir J 1996;9(11):2306-12
  • Macintyre AC, Cutler DJ. The potential role of lysosomes in tissue distribution of weak bases. Biopharm Drug Dispos 1988;9(6):513-26
  • Eling TE, Pickett RD, Orton TC, Anderson MW. A study of the dynamics of imipramine accumulation in the isolated perfused rabbit lung. Drug Metab Dispos 1975;3(5):389-99
  • Wilson AG, Law FC, Eling TE, Anderson MW. Uptake, metabolism and efflux of methadone in "single pass" isolated perfused rabbit lungs. J Pharmacol Exp Ther 1976;199(2):360-7
  • Kuipers JA, Boer F, Olieman W, First-pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model. Anesthesiology 1999;91(6):1780-7
  • He YL, Ueyama H, Tashiro C, Pulmonary disposition of propofol in surgical patients. Anesthesiology 2000;93(4):986-91
  • Levitt DG, Schnider TW. Human physiologically based pharmacokinetic model for propofol. BMC Anesthesiol 2005;5(1):4
  • Post C, Andersson RG, Ryrfeldt A, Nilsson E. Transport and binding of lidocaine by lung slices and perfused lung of rats. Acta Pharmacol Toxicol 1978;43(2):156-63
  • Howell RE, Lanken PN. Pulmonary accumulation of propranolol in vivo: sites and physiochemical mechanism. J Pharmacol Exp Ther 1992;263(1):130-5
  • Roerig DL, Kotrly KJ, Dawson CA, First-pass uptake of verapamil, diazepam, and thiopental in the human lung. Anesth Analg 1989;69(4):461-6
  • Aoki M, Okudaira K, Haga M, Contribution of rat pulmonary metabolism to the elimination of lidocaine, midazolam, and nifedipine. Drug Metab Dispos 2010;38(7):1183-8
  • Perreault S, Dumont L, Villiere V, Hepatic and extrahepatic metabolism of salbutamol in anesthetized rabbits. Drug Metab Dispos 1993;21(3):485-91
  • Cossum PA, Roberts MS, Yong AC, Kilpatrick D. Distribution and metabolism of nitroglycerin and its metabolites in vascular beds of sheep. J Pharmacol Exp Ther 1986;237(3):959-66
  • Cossum PA, Roberts MS, Kilpatrick D, Yong AC. Extrahepatic metabolism and distribution of aspirin in vascular beds of sheep. J Pharm Sci 1986;75(8):731-7
  • Tanigawara Y, He YL, Okumura K, Hori R. Pulmonary and hepatic disposition of hippuryl-L-histidyl-L-leucine. Chem Pharm Bull 1991;39(3):761-4
  • Imai T, Yoshigae Y, Hosokawa M, Evidence for the involvement of a pulmonary first-pass effect via carboxylesterase in the disposition of a propranolol ester derivative after intravenous administration. J Pharmacol Exp Ther 2003;307(3):1234-42
  • Anttila S, Tuominen P, Hirvonen A, CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 2001;11(6):501-9
  • Anttila S, Hakkola J, Tuominen P, Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking. Cancer Res 2003;63(24):8623-8
  • Kim JH, Sherman ME, Curriero FC, Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol Appl Pharmacol 2004;199(3):210-19
  • Kroon LA. Drug interactions with smoking. Am J Health 2007;64(18):1917-21
  • Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 2007;6(1):67-74
  • Nave R, McCracken N. Metabolism of ciclesonide in the upper and lower airways: review of available data. J Asthma Allergy 2008;1:11-18
  • Eixarch H, Haltner-Ukomadu E, Beisswenger C, Bock U. Drug delivery to the lung: permeability and physicochemical characteristics of drugs as the basis for a pulmonary biopharmaceutical classification system (pBCS). J Epith Bio Pharmacol 2010;3:1-14
  • Cooper A, Potter T, Luker T. Prediction of efficacious inhalation lung doses via the use of in silico lung retention quantitative structure-activity relationship models and in vitro potency screens. Drug Metab Dispos 2010;38(12):2218-25
  • Yeh HC, Schum GM. Models of Human-lung airways and their application to inhaled particle deposition. Bull Math Biol 1980;42(3):461-80
  • Asgharian B, Hofman W, Bergmann R. Particle deposition in a multiple-path model of the human lung. Aerosol Sci Tech 2001;34(4):332-9
  • Darquenne C, Harrington L, Prisk GK. Alveolar duct expansion greatly enhances aerosol deposition: a three-dimensional computational fluid dynamics study. Philos Trans R Soc A 2009;367(1896):2333-46
  • Sznitman J, Heimsch T, Wildhaber JH, Respiratory flow phenomena and gravitational deposition in a three-dimensional space-filling model of the pulmonary acinar tree. J Biomech Eng 2009;131(3):031010
  • Henry FS, Tsuda A. Radial transport along the human acinar tree. J Biomech Eng 2010;132(10):101001
  • Ma B, Darquenne C. Aerosol deposition characteristics in distal acinar airways under cyclic breathing conditions. J Appl Physiol 2011;110(5):1271-82
  • Elbert KJ, Schafer UF, Schafers HJ, Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res 1999;16(5):601-8
  • Foster KA, Oster CG, Mayer MM, Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 1998;243(2):359-66
  • Ehrhardt C, Collnot EM, Baldes C, Towards an in vitro model of cystic fibrosis small airway epithelium: characterisation of the human bronchial epithelial cell line CFBE41o. Cell Tissue Res 2006;323(3):405-15
  • Grainger CI, Greenwell LL, Lockley DJ, Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res 2006;23(7):1482-90
  • Oreffo VI, Morgan A, Richards RJ. Isolation of Clara cells from the mouse lung. Environ Health Perspect 1990;85:51-64
  • Suda T, Sato A, Sugiura W, Chida K. Induction of MHCclass-IIantigens on rat bronchial epithelial-cells by interferon-gamma and its effect on antigen presentation. Lung 1995;173(2):127-37
  • Kaufman DG. Biochemical studies of isolated hamster tracheal epithelium. Environ Health Perspect 1976;16:99-110
  • Robison TW, Dorio RJ, Kim KJ. Formation of tight monolayers of guinea-pig airway epithelial-cells cultured in an air-interface - bioelectric properties. Biotechniques 1993;15(3):468-73
  • Mathias NR, Kim KJ, Robison TW, Lee VHL. Development and characterization of rabbit tracheal epithelial-cell monolayer models for drug transport studies. Pharm Res 1995;12(10):1499-505
  • Welsh MJ. Ion transport by primary cultures of canine tracheal epithelium: methodology, morphology, and electrophysiology. J Membr Biol 1985;88(2):149-63
  • Sime A, McKellar Q, Nolan A. Method for the growth of equine airway epithelial cells in culture. Res Vet Sci 1997;62(1):30-3
  • Lin H, Li H, Cho HJ, Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. J Pharm Sci 2007;96(2):341-50
  • Forbes B, Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 2005;60(2):193-205
  • Saha P, Kim KJ, Yamahara H, Influence of lipophilicity on beta-blocker permeation across rat alveolar epithelial-cell monolayers. J Control Release 1994;32(2):191-200
  • Matsukawa Y, Lee VH, Crandall ED, Kim KJ. Size-dependent dextran transport across rat alveolar epithelial cell monolayers. J Pharm Sci 1997;86(3):305-9
  • Morimoto K, Yamahara H, Lee VHL, Kim KJ. Dipeptide transport across rat alveolar epithelial-cell monolayers. Pharm Res 1993;10(11):1668-74
  • Matsukawa Y, Yamahara H, Yamashita F, Rates of protein transport across rat alveolar epithelial cell monolayers. J Drug Target 2000;7(5):335-42
  • Yacobi NR, Malmstadt N, Fazlollahi F, Mechanisms of alveolarepithelial translocation of a defined population of nanoparticles. Am J Respir Cell Mol Biol 2010;42(5):604-14
  • Fazlollahi F, Sipos A, Kim YH, Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers. Int J Nanomed 2011;6:2849-57
  • Kim KJ, Fandy TE, Lee VH, Net absorption of IgG via FcRn-mediated transcytosis across rat alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 2004;287(3):L616-22
  • Steimer A, Laue M, Franke H, Porcine alveolar epithelial cells in primary culture: morphological, bioelectrical and immunocytochemical characterization. Pharm Res 2006;23(9):2078-93
  • Steimer A, Franke H, Haltner-Ukomado E, Monolayers of porcine alveolar epithelial cells in primary culture as an in vitro model for drug absorption studies. Eur J Pharm Biopharm 2007;66(3):372-82
  • Eaton EA, Walle UK, Wilson HM, Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br J Clin Pharmacol 1996;41(3):201-6
  • Sheets PL, Yost GS, Carlson GP. Benzene metabolism in human lung cell lines BEAS-2B and A549 and cells overexpressing CYP2F1. J Biochem Mol Toxicol 2004;18(2):92-9
  • Sporty JL, Horalkova L, Ehrhardt C. In vitro cell culture models for the assessment of pulmonary drug disposition. Expert Opin Drug Metab Toxicol 2008;4(4):333-45
  • Shen J, Lee VH. Application of epithelial cell culture in drug transport in the respiratory tract. Methods Mol Biol 2002;188:217-32
  • Grainger CI, Greenwell LL, Martin GP, Forbes B. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. Eur J Pharm Biopharm 2009;71(2):318-24
  • Mathias NR, Timoszyk J, Stetsko PI, Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J Drug Target 2002;10(1):31-40
  • Nave R, Fisher R, Zech K. In vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices. Biopharm Drug Dispos 2006;27(4):197-207
  • Foe K, Brown KF, Seale JP. Comparative kinetics of metabolism of beclomethasone propionate esters in human lung homogenates and plasma. J Pharm Sci 2000;89(9):1143-50
  • Sahasranaman S, Issar M, Hochhaus G. Metabolism of mometasone furoate and biological activity of the metabolites. Drug Metab Dispos 2006;34(2):225-33
  • Wohlsen A, Martin C, Vollmer E, The early allergic response in small airways of human precision-cut lung slices. Eur Respir J 2003;21(6):1024-32
  • Fisher AB, Furia L, Chance B. Evaluation of redox state of isolated perfused rat lung. Am J Physiol 1976;230(5):1198-204
  • Jeppsson AB, Nilsson E, Waldeck B. Formoterol and salmeterol are both long-acting compared to terbutaline in the isolated-perfused and ventilated guinea-pig lung. Eur J Pharmacol 1994;257(1-2):137-43
  • Westcott JY, Henson J, McMurtry IF, O'Brien RF. Uptake and metabolism of endothelin in the isolated perfused rat lung. Exp Lung Res 1990;16(5):521-32
  • Minchin RF, Boyd MR. Uptake and metabolism of doxorubicin in isolated perfused rat lung. Biochem Pharmacol 1983;32(18):2829-32
  • Bakhle YS, Chelliah R. Metabolism and uptake of adenosine in rat isolated lung and its inhibition. Br J Pharmacol 1983;79(2):509-15
  • Byron PR, Sun Z, Katayama H, Rypacek F. Solute absorption from the airways of the isolated rat lung. IV. Mechanisms of absorption of fluorophore-labeled poly-alpha,beta-[N(2-hydroxyethyl)-DL-aspartamide]. Pharm Res 1994;11(2):221-5
  • Manford F, Tronde A, Jeppsson AB, Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung. Eur J Pharm Sci 2005;26(5):414-20
  • Tronde A, Bosquillon C, Forbes B. The isolated perfused lung for drug absorption studies. In: Ehrhardt C, Kim K, editors. Drug absorption studies: in situ, in vitro and in silico models. Springer, New York; 2008. p. 135-63
  • Mehendale HM, Angevine LS, Ohmiya Y. The isolated perfused lung–a critical evaluation. Toxicology 1981;21(1):1-36
  • Freiwald M, Valotis A, Kirschbaum A, Monitoring the initial pulmonary absorption of two different beclomethasone dipropionate aerosols employing a human lung reperfusion model. Respir Res 2005;6:21
  • Gnadt M, Trammer B, Kardziev B, Comparison of the bronchodilating effects of inhaled beta(2)-agonists after methacholine challenge in a human lung reperfusion model. Eur J Pharm Biopharm 2012;81(3):617-26
  • Ohmura S, Sugano A, Kawada M, Yamamoto K. Pulmonary uptake of ropivacaine and levobupivacaine in rabbits. Anesth Analg 2003;97(3):893-7
  • Roerig D, Audi S, Ahlf S, Mathematical model for the pulmonary disposition of lidocaine (lido) in the isolated rabbit lung (IPL). FASEB J 1996;10(3):586
  • Weiss M, Reekers M, Vuyk J, Boer F. Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients. J Pharmacokinet Pharmacodyn 2011;38(2):165-78
  • Upton RN, Ludbrook G. A physiologically based, recirculatory model of the kinetics and dynamics of propofol in man. Anesthesiology 2005;103(2):344-52
  • Liu X, Wang JY, Khlentzos AM, Influence of perfusate composition on drug disposition in the in-situ perfused rat lung. Int J Pharm 2009;382(1-2):192-7
  • Hayashi Y, Sumikawa K, Yamatodani A, Quantitative analysis of pulmonary clearance of exogenous dopamine after cardiopulmonary bypass in humans. Anesth Analg 1993;76(1):107-12
  • Boer F, Hoeft A, Scholz M, Pulmonary distribution of alfentanil and sufentanil studied with system dynamics analysis. J Pharmacokinet Biopharm 1996;24(2):197-218
  • Ferner RE. Post-mortem clinical pharmacology. Br J Clin Pharmacol 2008;66(4):430-43
  • Kuehl PJ, Barrett EG, McDonald JD, Formulation development and in vivo evaluation of a new dry powder formulation of albuterol sulphate in beagle dogs. Pharm Res 2010;27(5):894-904
  • Smith DJ, Gambone LM, Tarara T, Liquid dose pulmonary instillation of gentamicin PulmoSpheres formulations: tissue distribution and pharmacokinetics in rabbits. Pharm Res 2001;18(11):1556-61
  • Cooper AE, Ferguson D, Grime K. Optimisation of DMPK by the inhaled route: challenges and approaches. Curr Drug Metab 2012;13(4):457-73
  • Pang Y, Sakagami M, Byron PR. The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition. Eur J Pharm Sci 2005;25(4-5):369-78
  • Clearie KL, Williamson PA, Vaidyanathan S, Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. Br J Clin Pharmacol 2010;69(6):637-44
  • Rohatagi S, Rhodes GR, Chaikin P. Absolute oral versus inhaled bioavailability: significance for inhaled drugs with special reference to inhaled glucocorticoids. J Clin Pharmacol 1999;39(7):661-3
  • Esposito-Festen JE, Zanen P, Tiddens HA, Lammers JW. Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size. Br J Clin Pharmacol 2007;64(3):328-34
  • Jaafar-Maalej C, Andrieu V, Elaissari A, Fessi H. Assessment methods of inhaled aerosols: technical aspects and applications. Expert Opin Drug Deliv 2009;6(9):941-59
  • Brindley C, Falcoz C, Mackie AE, Bye A. Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers. Clin Pharmacokinet 2000;39(Suppl 1):1-8
  • Cassidy JP, Amin N, Marino M, Insulin lung deposition and clearance following Technosphere(R) insulin inhalation powder administration. Pharm Res 2011;28(9):2157-64
  • Biddiscombe MF, Meah SN, Underwood SR, Usmani OS. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition. J Aerosol Med Pulm Drug Deliv 2011;24(3):165-73
  • Lenney W, Edenborough F, Kho P, Kovarik JM. Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. J Cyst Fibros 2011;10(1):9-14
  • Lee ZH, Berridge MS, Nelson AD, Heald DL. The effect of scatter and attenuation on aerosol deposition as determined by gamma scintigraphy. J Aerosol Med 2001;14(2):167-83
  • Bailey DL. Imaging the airways in 2006. J Aerosol Med 2006;19(1):1-7
  • Conway J. Lung imaging - two dimensional gamma scintigraphy, SPECT, CT and PET. Adv Drug Deliv Rev 2012;64(4):357-68
  • Newman S, Fleming J. Challenges in assessing regional distribution of inhaled drug in the human lungs. Expert Opin Drug Deliv 2011;8(7):841-55
  • Thompson RB, Finlay WH. Using MRI to measure aerosol deposition. J Aerosol Med Pulm Drug Deliv 2012;25(2):55-62
  • Martin AR, Thompson RB, Finlay WH. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles. J Aerosol Med Pulm Drug Deliv 2008;21(4):335-42
  • Sood BG, Shen Y, Latif Z, Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res 2008;64(2):159-64
  • Fehniger TE, Vegvari A, Rezeli M, Direct demonstration of tissue uptake of an inhaled drug: proof-of-principle study using matrix-assisted laser desorption ionization mass spectrometry imaging. Anal Chem 2011;83(21):8329-36
  • Hein S, Bur M, Schaefer UF, Lehr CM. A new pharmaceutical aerosol deposition device on cell cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations. Eur J Pharm Biopharm 2011;77(1):132-8
  • Nichols JE, Cortiella J. Engineering of a complex organ: progress toward development of a tissue-engineered lung. Proc Am Thorac Soc 2008;5(6):723-30
  • Huh D, Matthews BD, Mammoto A, Reconstituting organ-level lung functions on a chip. Science 2010;328(5986):1662-8
  • Leonard AK, Sileno AP, Brandt GC, In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo. Int J Pharm 2007;335(1-2):138-46
  • Mace K, Bowman ED, Vautravers P, Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur J Cancer 1998;34(6):914-20
  • Mathias NR, Kim KJ, Lee VH. Targeted drug delivery to the respiratory tract: solute permeability of air-interface cultured rabbit tracheal epithelial cell monolayers. J Drug Target 1996;4(2):79-86
  • Forbes B, Shah A, Martin GP, Lansley AB. The human bronchial epithelial cell line 16HBE14o- as a model system of the airways for studying drug transport. Int J Pharm 2003;257(1-2):161-7
  • Cavet ME, West M, Simmons NL. Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells. Antimicrob Agents Chemother 1997;41(12):2693-8
  • Borchard G, Cassara ML, Roemele PE, Transport and local metabolism of budesonide and fluticasone propionate in a human bronchial epithelial cell line (Calu-3). J Pharm Sci 2002;91(6):1561-7
  • dos Santos T, Varela J, Lynch I, Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 2011;6(9):e24438

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.